38-502:BRAFTOVI/MEKTOVI Combination Therapy Specified Drug Use Survey(CRC)
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Primary outcome(s): [Safety]Occurrence status of adverse drug reactions and infections, Occurrence status of adverse drug reactions corresponding to specified safety concerns, Factors that are considered to affect safety Specified safety concerns: Cutaneous malignancies, palmar-plantar erythrodysaesthesia syndrome, eye disorders, cardiac dysfunction, hypertension, rhabdomyolysis, hepatic dysfunction, and haemorrhage [Efficacy]Antitumor effect and overall survival (OS)
创建时间：
2021-03-15
